home / stock / cbiif / cbiif news

CBIIF News and Press, Skylight Health Group From 07/09/19

Stock Information
Company Name: Skylight Health Group
Stock Symbol: CBIIF
Market: OTC
Website: skylighthealthgroup.com
Menu
CBIIF CBIIF Quote CBIIF Short CBIIF News CBIIF Articles CBIIF Message Board
Get CBIIF Alerts

News, Short Squeeze, Breakout and More Instantly...
CBIIF - CB2 Insights and Premier Health Group Move to Second Phase of Primary Care Physician Tools for Medical Cannabis Evaluations

TORONTO, July 09, 2019 (GLOBE NEWSWIRE) -- CB2 Insights (CSE:CBII; OTCQB: CBIIT) (“CB2” or the “Company”), a leading data-driven company focused on bringing real-world evidence driven from the point-of-care to the medical cannabis community, has successfully comp...
CBIIF - CB2 Insights Expands Clinical Division into New Jersey with the Asset Acquisition of New Jersey Alternative Medicine Clinics

TORONTO, June 25, 2019 (GLOBE NEWSWIRE) -- CB2 Insights (CSE:CBII; OTCQB: CBIIF) (“CB2” or the “Company”), a leading data-driven company focused on bringing real-world evidence driven from the point-of-care to the medical cannabis community, today announced it wi...

CBIIF - CB2 Insights Announces Annual General & Special Meeting of Shareholders and Corporate Update

TORONTO, June 24, 2019 (GLOBE NEWSWIRE) -- CB2 Insights (CSE:CBII; OTCQB: CBIIF) (“CB2” or the “Company”), a leading data-driven company focused on bringing real-world evidence driven from the point-of-care to the medical cannabis community, has announced the dat...

CBIIF - Sharing Knowledge: Clinical Data for the Medical Cannabis Industry

The amount of clinical data relating to medical cannabis research is growing at an unprecedented rate, fueling demand for systems that can disseminate critical information to stakeholders.  These are exciting times for the medical cannabis industry. After decades of research being hel...
CBIIF - CB2 Insights reports Q1 results

CB2 Insights ( OTCQB:CBIIF ): Q1 GAAP EPS of -C$0.03. More news on: CB2 Insights Inc., Earnings news and commentary, , Read more ...

CBIIF - CB2 Insights Posts Strong Growth in Clinical Revenue and Drives Operating Efficiencies in Q1 2019

TORONTO, May 30, 2019 (GLOBE NEWSWIRE) -- CB2 Insights (CSE:CBII; OTCQB:CBIIF) (“ CB2 ” or the “ Company ”), a leading technology company focused on mainstreaming medical cannabis to the healthcare industry through Real World Evidence (“RWE”), t...

CBIIF - CB2 Insights to Host Q12019 Earnings Call on May 31, 2019

TORONTO, May 27, 2019 (GLOBE NEWSWIRE) -- CB2 Insights (“CB2” or the “Company”) (CSE:CBII; OTCQB:CBIIF), a leading provider of medical cannabis-focused Real World Evidence to the healthcare sector, will be hosting its Q1 2019 earnings call on Friday, May 31, 2019...
CBIIF - CB2 Insights Announces Ticker Symbol Change on OTCQB

TORONTO, May 17, 2019 (GLOBE NEWSWIRE) -- CB2 Insights (“CB2” or the “Company”) (CSE:CBII) (OTCQB:CBIIF) a leading technology company focused on mainstreaming medical cannabis to the healthcare industry through Real-World Evidence, today announced that effective ...

Previous 10 Next 10